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Abstract
Background: In vitro models are indispensable study objects in the fields of cell and molecular
biology, with advantages such as accessibility, homogeneity of the cell population, reproducibility,
and growth rate. The Caco-2 cell line, originating from a colon carcinoma, is a widely used in vitro
model for small intestinal epithelium. Cancer cells have an altered metabolism, making it difficult to
infer their representativity for the tissue from which they are derived. This study was designed to
compare the protein expression pattern of Caco-2 cells with the patterns of intestinal epithelial
cells from human small and large intestine. HT-29 intestinal cells, Hep G2 liver cells and TE 671
muscle cells were included too, the latter two as negative controls.
Results: Two-dimensional gel electrophoresis was performed on each tissue and cell line protein
sample. Principal component and cluster analysis revealed that global expression of intestinal
epithelial scrapings differed from that of intestinal epithelial cell lines. Since all cultured cell lines
clustered together, this finding was ascribed to an adaptation of cells to culture conditions and their
tumor origin, and responsible proteins were identified by mass spectrometry. When investigating
the profiles of Caco-2 cells and small intestinal cells in detail, a considerable overlap was observed.
Conclusion: Numerous proteins showed a similar expression in Caco-2 cells, HT-29 cells, and
both the intestinal scrapings, of which some appear to be characteristic to human intestinal
epithelium in vivo. In addition, several biologically significant proteins are expressed at comparable
levels in Caco-2 cells and small intestinal scrapings, indicating the usability of this in vitro model.
Caco-2 cells, however, appear to over-express as well as under-express certain proteins, which
needs to be considered by scientists using this cell line. Hence, care should be taken to prevent
misinterpretation of in vitro obtained findings when translating them to the in vivo situation.
Background
In vitro cell models play an important role in understand-
ing cellular events related to (patho)physiological condi-
tions in humans. Many advantages such as accessibility,
homogeneity of the cell population, reproducibility,
growth rate, and hence the amount of material for analy-
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sis make them indispensable study objects in the search
for molecular mechanisms. The differentiation process of
intestinal cells, pathologies related with inflammatory
conditions in the intestine, but also the adaptation of
intestinal cells to certain nutritional conditions are often
studied by an in vitro approach using intestinal epithelial
cell models [1-5]. The human Caco-2 and HT-29 cell lines
are commonly used models representing features of the
human intestinal epithelium. Caco-2 cells were derived
from a human colon adenocarcinoma, and they differen-
tiate spontaneously in vitro under standard culture condi-
tions thereby exhibiting enterocyte-like structural and
functional characteristics [6]. In differentiated state, they
mimic typical characteristics of the human small intesti-
nal epithelium, like a well-developed brush border with
associated enzymes such as alkaline phosphatase and
sucrase isomaltase [6]. Nevertheless, the Caco-2 cell
model is different from the small intestine in several
aspects, and their phenotype is dependent on the time in
culture [7,8]. The HT-29 cell line is also of human colon
adenocarcinoma origin, and cannot differentiate sponta-
neously in vitro under standard conditions, representing
undifferentiated colonic epithelial cells [9].
Caco-2, HT-29 cells, and many other widely used cell lines
originate from tumour tissue, which alters the cellular
metabolism drastically compared to physiological condi-
tions. Therefore, it is difficult to interpret how representa-
tive a specific cell line is for the tissue from which it is
derived. Furthermore, in comparison with the in vivo situ-
ation with influences from different neighbouring cells,
(neuro)endocrine regulators and blood flow, the in vitro
model is relatively simple. Although this is ideal for spe-
cific research questions, it complicates the translatability
of in vitro results to in vivo situations. Above all, it is not
clear if cells in culture retain the gene expression profiles
of their in vivo counterparts. A study regarding the gene
expression patterns in 60 human cancer cell lines, includ-
ing colon cancer cell lines, revealed that the tissue from
which the cells are derived is the main factor accounting
for the variation in gene expression [10]. Gene expression
was also investigated at a large scale in Caco-2 and HT-29
cells using microarray technology [11]. Another study
revealed novel proteins which were associated with prolif-
eration and differentiation in Caco-2 cells in relation to
colon carcinogenesis [12]. However, differentiated Caco-
2 cells, and also HT-29 cells are often used to reproduce
features of the intestinal epithelium per se. 
A suitable and innovative method to evaluate the validity
of such models for the 'normal' epithelium is by investi-
gating similarities and differences in protein expression
between cultured intestinal epithelial cells and epithelial
scrapings obtained from human intestine. Protein isolates
of cultured Caco-2 cells and HT-29 were subjected to two-
dimensional gel electrophoresis (2-DE) and compared
with the 2-DE patterns generated from normal epithelium
from the small and large intestine. The Caco-2 cells are
very often cultured on permeable supports. This way of
culturing polarized cells resembles the in vivo situation
more closely, as the cells can take up and secrete mole-
cules on both sides of the monolayer. The supports that
were applied in this study were collagen-coated, as this
has been shown to promote cell attachment and growth
leading to confluence of the Caco-2 monolayer more rap-
idly [13]. In addition, ultrastructural features of the cell
layer were thoroughly investigated in that study and
appeared to mimic those of the small intestinal epithe-
lium, which is relevant for a good cell model. As a nega-
tive control, protein profiles of the human Hep G2
hepatoma cell line (liver) and the TE 671 rhabdomyosar-
coma cell line (muscle) were used.
Results
Protein expression profiles of the intestinal scrapings and 
cell lines
For each tissue or cell line under study, three replicate gels
were made of biological independent samples, except for
the large intestinal scrapings, of which only 2 independ-
ent samples could be obtained. A dendogram (Figure 1)
generated by unsupervised hierarchical clustering of the
expression data of 2-D patterns revealed that the profiles
of the epithelial scrapings of both small and large intes-
tine were separated from those of the cell lines. In the cell
line cluster, profiles of cells of epithelial origin (Caco-2,
HT-29 and Hep G2) were separated from the profile of
cells of mesenchymal origin (TE 671). Differentiated as
well as undifferentiated TE 671 cells were tested, but the
2-D patterns of these cells were similar. The differentia-
tion process induced some obvious protein changes, such
as an up-regulation of expression of the spot which con-
tains vimentin. However, overall expression of the undif-
ferentiated and differentiated TE 671 cells were alike and
clustered together in all analyses described below. There-
fore, only data of the differentiated cells were shown in
detail, as the main focus is the behaviour of the intestinal
cells.
To get further insight in how 2-D patterns of intestinal
Caco-2 cells (partially and fully differentiated) and HT-29
cells are related to profiles of small and large intestinal
epithelial scrapings, a principal component analysis
(PCA) was performed. PCA allows for grouping of cells
with overall similar protein expression characteristics and
for identifying proteins which are responsible for the dif-
ferences between the groups. The plot shown in Figure 2A
is a simple scatter plot of the first two principal compo-
nents (PC). PC1 and PC2 explain 37.3% and 13.8% of the
total variation, respectively. Triplicate gels cluster together
which indicates that the biological variation is responsibleBMC Genomics 2007, 8:91 http://www.biomedcentral.com/1471-2164/8/91
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for the clear separation of the different samples. Along
PC1, three distinct groups are visible, of which one corre-
sponds to all cultured cell lines, independent of tissue ori-
gin. In the cluster of the cell lines, three sub-clusters exist
along PC2 corresponding to profiles from TE 671 cells,
HT-29 together with Hep G2 cells and Caco-2 cells, inde-
pendent of their stage of differentiation. When blood-
derived proteins are removed from the data set, the PCA
plot is very similar but PC1 explains only 29.8% of the
total variation, largely because profiles of the small and
large intestinal cells move closer towards the cell lines
along PC1, whereas PC2 explains 15.7% (data not
shown). In addition, removing the blood proteins for gen-
erating the dendogram did not influence the branching.
Protein data of all in vitro cell cultures were used to gener-
ate a set of protein spots (within a circle of 25% from the
plot centre), which have the same relative abundance in
all types of cell lines studied. These proteins are present in
all in vitro cultured cells included in this analysis, and
seem not much contributory to the specific phenotype of
a certain cell line. Therefore, another PCA was performed,
in which expression data of the 25% proteins common for
in vitro cell cultures were subtracted from the data set
(without blood proteins), so proteins that make a cell line
unique contribute more to the overall pattern. The out-
come of the analysis, displayed as a scatter plot of PC1 and
PC2, revealed that protein expression patterns of scrap-
ings and cell lines are still separated (Figure 2B). Along
PC1 (explaining 24.9% of the variation), the 2-D profiles
of the HT-29 cells move in the direction of the profiles of
the colonic scrapings. Along PC2 (explaining 17.4% of
the variation) the profiles of Caco-2 cells appear at a sim-
ilar position as those of the small intestinal cells, but this
was already visible in Figure 2A. Along PC1 and PC2, the
profiles of the TE 671 cells move further away from the
profiles of all other, epithelial cells.
Protein expression in the intestinal scrapings and cell lines
In PDQuest, 2-D patterns of all protein isolates under
study were compared and resulted in 131 differentially
expressed proteins. In addition, 8 protein spots were
selected that showed a similar expression pattern in all
isolates. Out of 139 protein spots, 94 spots (68%) were
Unsupervised hierarchical clustering of protein profiles Figure 1
Unsupervised hierarchical clustering of protein profiles. A dendogram, generated by unsupervised hierarchical cluster-
ing of protein expression data of 2-D profiles of protein isolates obtained from three biological replicates of small intestinal 
scrapings, partially and fully differentiated Caco-2 cells, HT-29 cells, Hep G2 cells and TE 671 cells. Profiles of large intestine (1) 
and (2) come from one human sample.BMC Genomics 2007, 8:91 http://www.biomedcentral.com/1471-2164/8/91
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PCA of protein profiles Figure 2
PCA of protein profiles. PCA projection of protein profiles obtained by 2-DE in a scatter plot using the entire data set (A) 
and the data set after subtracting data points corresponding to proteins common for in vitro cell cultures (B). In panel A, PC1 
and PC2 explain 37.3% and 13.8% of the total variation, respectively. In panel B, PC1 and PC2 explain 24.9% and 17.4% of the 
total variation, respectively. Open symbols and closed symbols represent 2-D profiles of cell lines and epithelial scrapings, 
respectively, as shown in panel A. The cluster numbers containing proteins which are mainly responsible for separation 
between groups are depicted next to the arrows in panel A. SI, small intestine; LI, large intestine; EC, epithelial cells.
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identified by matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry (MALDI-TOF MS) [see
Additional file 1 for identification characteristics]. Identi-
fied proteins were grouped in 12 clusters according to
their expression pattern in the analyzed samples. These
clusters of protein spots are shown in Figure 3 and 4, in
which log-transformed expression values of the biological
replicates of different samples are shown in color [See
additional file 2 for the averaged spot intensities and the
standard deviation of these spots in each tissue and cell
line]. The spot numbers correspond to those indicated in
Figure 5. In this figure, a 2-D pattern of 5-day-differenti-
ated Caco-2 cells (Figure 5A), and a 2-D pattern of a small
intestinal epithelial scraping (Figure 5B) are shown to give
an indication of the overlap of the profiles. The spot num-
bers of spots which were not present in one of these pat-
terns are indicated in bold, italic. Figure 6 shows 2-D
patterns of large intestinal epithelium, HT-29, Hep G2
and TE 671 cells to obtain a general view on the differ-
ences and similarities of the protein expression.
Cluster 1 contains proteins which show a high expression
in both intestinal epithelial scrapings relative to the in
vitro cell cultures. Cluster 2 and 3 consist of proteins with
a high expression level in small and large intestinal scrap-
ings, respectively. Proteins with low expression levels in
the scrapings are grouped in cluster 4. Cluster 5 contains
proteins with a high expression in all cells of epithelial
origin, and cluster 6 contains proteins with a low expres-
sion in those cells. Cluster 7 shows proteins with a high
expression in all protein isolates of intestinal origin, and
protein spots with a high expression in small intestinal
epithelium and Caco-2 cells are shown in cluster 8. Clus-
ter 9 and 10 represent proteins with a high and low
expression in Caco-2 cells, respectively. Cluster 11 con-
tains proteins mainly expressed in Hep G2 but with co-
expression in other relevant cell types. The last cluster,
cluster 12 shows proteins with a relatively similar expres-
sion level in all protein isolates.
Discussion
The current proteomics approach aims to obtain a better
insight in the expression patterns of human intestinal epi-
thelial cells and the commonly used in vitro models for
these cells, Caco-2 cells and HT-29 cells, both derived of
human intestinal adenocarcinoma. This information is
highly relevant to researchers using such models, and aim-
ing for translating data to the in vivo situation.
When comparing the 2-D pattern of Caco-2 cells and
small intestinal cells, it becomes apparent that many pro-
tein spots are present in both profiles, indicating a great
deal of overlap in the type of proteins expressed, support-
ing the usability of this in vitro model. However, several
high abundant proteins in human epithelial cells of the
small intestine are not expressed or expressed at low levels
in Caco-2 cells, and vice versa. This might be caused by the
transformed status of Caco-2 cells and an adaptation of
their metabolism to growth conditions outside the body.
This is supported by the clustering data, which revealed a
separation of the epithelial scrapings and all in vitro cell
lines, irrespective of their tissue origin, suggesting that the
protein expression profiles were quite similar among each
of the cell lines, but different from the protein profiles of
epithelium in vivo. When exploring the clusters explaining
the main variation in expression, noticeably, typical pro-
teins with a high expression in the scrapings are hemo-
globin alpha and beta, serum albumin and transthyretin,
which appear to originate from blood cells. This finding
demonstrates the difficulty of obtaining pure cell isolates,
and points to the advantage of using in vitro cell lines,
which consist of a homogenous cell population.
Several other proteins are responsible for the distinction
of the in vitro and in vivo proteomes. First, intestinal fatty-
acid binding protein (FABP) expression is only observed
in the protein profiles of intestinal scrapings, and the
expression is highest in small intestinal epithelium. This
was observed in another study as well, in which levels
were tested at different segments of the human intestinal
tract [14]. Liver FABP is highly expressed in intestinal
scrapings, but shows expression in liver Hep G2 and Caco-
2 cells too. In the latter cells, its expression increases with
differentiation, which is in agreement with a previous
study [15]. Another member of the FABP family is cellular
retinol-binding protein (RBP) II, which is solely expressed
in the small intestinal epithelial scrapings. This vitamin A-
binding protein is abundant in the human small intesti-
nal mucosa and is localized to the villus-associated ente-
rocytes by immunohistochemistry [16]. In adult rats,
expression of cellular RBP II is restricted to villus-associ-
ated enterocytes in the proximal small intestine [17]. This
protein may be important for intestinal absorption and/or
metabolism of retinol. It is also reported in literature that
Caco-2 cells express the protein, and that the expression
increases with differentiation [18], but we failed to detect
the protein in the profiles of these cells. Two proteins
involved in fructose metabolism, ketohexokinase and
fructose-bisphosphate aldolase B, show a high expression
in the small intestine. The latter enzyme is known to be
primarily expressed in liver, small intestine, and kidney
[19]. In Hep G2 cells, aldolase B mRNA was shown to be
weakly expressed [20]. In comparison, differentiated
Caco-2 cells express fructose-bisphosphate aldolase A and
C mRNA [21], and recently, we identified isoform A pro-
tein in Caco-2 cells [22]. To recapitulate, several proteins
with a role in lipid and carbohydrate metabolism are
higher expressed, or exclusively expressed in the in vivo
intestinal material. This may be a reflection of the intes-
tine's capacity in absorbing and metabolizing complexBMC Genomics 2007, 8:91 http://www.biomedcentral.com/1471-2164/8/91
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Clustering of identified protein spots according to the expression levels in analyzed samples Figure 3
Clustering of identified protein spots according to the expression levels in analyzed samples. Identified protein 
spots grouped in different clusters (cluster 1–5) according to the expression level in different samples. Triplicate spot intensi-
ties are shown by a colour range; bright red, black, and bright green represent high, average, and low levels of protein expres-
sion.
Expression Pattern
a)   Spot  Swiss-  Protein  Name  Cl. 
   No.  Prot    No. 
1 2 3 4 5 6 7    Acc.  No.    
   9 2
b)  P68871 H emoglobin beta  1 
   9 3
b)  P69905 H emoglobin alpha  1 
   21
b)  P02768  Serum albumin  1 
   56
b)  P02768  Serum albumin  1 
   45  P00915  Carbonic anhydrase 1  1 
   8 5
b)  P02766 T ransthyretin  1 
   18-1  P30101  Protein disulfide-isomerase A3  1 
   18-2  P12955 X aa-Pro dipeptidase   1 
   43  P28062  Proteasome subunit beta type 8  1 
   33  P14550  Alcohol dehydrogenase [NADP ]   1 
   61  P35232  Prohibitin  1 
   8 6  P12104 F atty acid-binding protein, intestinal   1 
   44  P30086  Phosphatidylethanolamine-binding protein   1 
   8 7  P07148 Fatty acid-binding protein, liver   1 
   65-1  P30085 UMP-CMP kinase  1 
   65-2  P32119  Peroxiredoxin 2  1 
   90  P23528  Cofilin-1  1 
   8 3  P50120 Retinol-binding protein II, cellular   2 
   36  P05062 F ructose-bisphosphate aldolase B  2 
   35  P05062 F ructose-bisphosphate aldolase B  2 
   52  P50053 K etohexokinase  2 
   75  P28065  Proteasome subunit beta type 9   2 
   8 1  P00167  Cytochrome b5   2 
   51  P78417 G lutathione transferase omega 1  2 
   11 Q9Y2T3 Guanine deaminase   2 
   49-1  P30039 MAWD binding protein  2 
   49-2  P25786  Proteasome subunit alpha type 1   2 
   48
b)  P02768  Serum albumin   3 
   27  P14866 H eterogeneous nuclear ribonucleoprotein L  4 
   8 2 Q9Y2B0 MIR-interacting saposin-like protein precursor   4 
   4  P07437 Tubulin beta-2   4 
   29  P14866 H eterogeneous nuclear ribonucleoprotein L   4 
   2  P07237  Protein disulfide-isomerase  4 
   74  P13693   Translationally-controlled tumor protein   4 
   80  P60660 Myosin light polypeptide 6  4 
   19  P61979 Heterogeneous nuclear ribonucleoprotein K   4 
   25  P49411  Elongation factor Tu  4 
   3  P11021  78 kDa glucose-regulated protein  4 
   38  P22626 H eterogeneous nuclear ribonucleoproteins A2/B1   4 
   7 Q 15084  Protein disulfide-isomerase A6   4 
   1  P27797  Calreticulin  4 
   57 Q 13162  Peroxiredoxin 4   4 
   62  P35232  Prohibitin  4 
   37  P22626 H eterogeneous nuclear ribonucleoproteins A2/B1   4 
   9 4  P61604  10 kDa heat shock protein  4 
   9  P10809  60 kDa heat shock protein  4 
   72  P31947  Epithelial cell marker protein 1  5 
   34 Q 16762 Thiosulfate sulfurtransferase   5 
   60  P50224 M onoamine-sulfating phenol sulfotransferase   5 
a) 1, Small intestine; 2, Large intestine; 3, Caco-2 5d; 4, Caco-2 15d; 5, HT-29; 6, Hep G2; 7, TE 671. 
b) The abundances of blood-derived protein spots were subtracted from the total gel density for correct normalization. BMC Genomics 2007, 8:91 http://www.biomedcentral.com/1471-2164/8/91
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Clustering of identified protein spots according to the expression levels in analyzed samples (continuation of Figure 3) Figure 4
Clustering of identified protein spots according to the expression levels in analyzed samples (continuation of 
Figure 3). Identified protein spots grouped in different clusters (cluster 5–12) according to the expression level in different 
samples. Triplicate spot intensities are shown by a colour range; bright red, black, and bright green represent high, average, and 
low levels of protein expression.
Expression Pattern
a)   Spot  Swiss-  Protein  Name  Cl. 
   No.  Prot    No. 
1 2 3 4 5 6 7    Acc.  No.    
   59  P09525  Annexin A4   5 
   79  P60660 Myosin light polypeptide 6  5 
   17  P05787 K eratin, type II cytoskeletal 8  5 
   78  P62158   Calmodulin  5 
   8_1  P08670 Vimentin  6 
   8_2  P05787 K eratin, type II cytoskeletal 8  6 
   8 4  P09382   Galectin-1  6 
   54  P04792 H eat-shock protein beta-1   6 
   6 Q 15293 R eticulocalbin-1 precursor   6 
   32  P54868 Hydroxymethylglutaryl-CoA synthase  7 
   16  P35900 Keratin, type I cytoskeletal 20   7 
   10  P35900 Keratin, type I cytoskeletal 20   7 
   64  P09211 G lutathione S-transferase P  7 
   23  P31040  Succinate dehydrogenase   8 
   50  P50225  Sulfotransferase 1A1 8 
   28 Q16822  Phosphoenolpyruvate carboxykinase, mit. 8 
   26  P04181 O rnithine aminotransferase 8 
   66 Q9NRV9 Heme-binding protein 1 8 
   22  P13674  Prolyl 4-hydroxylase alpha-1 9 
   14  P12277  Creatine kinase B-type   9 
   70  P07858  Cathepsin B precursor   9 
   53  P30084  Enoyl-CoA hydratase 9 
   39  P21796 V oltage-dependent anion-selective channel protein 1 9 
   20  P38646  75 kDa glucose regulated protein 9 
   55  P30048 Thioredoxin-dependent peroxide reductase 9 
   5  P06576  ATP synthase beta chain, mitochondrial   9 
   40  P17931 G alectin-3 9 
   73  P15374 Ubiquitin carboxyl-terminal hydrolase isozyme L3   10 
   71  P28066  Proteasome subunit alpha type 5   10 
   69  P52565 Rho GDP-dissociation inhibitor 1  10 
   24  P00352 R etinal dehydrogenase 1  10 
   63  P28070  Proteasome subunit beta type 4  10 
   9 1  P07737  Profilin-1   10 
   42 Q06830  Peroxiredoxin 1   10 
   30 O60701 UDP-glucose 6-dehydrogenase   11 
   67  P02753  Plasma retinol-binding protein   11 
   77  P07237  Protein disulfide-isomerase  11 
   13  P07237  Protein disulfide-isomerase  11 
   76  P07237  Protein disulfide-isomerase   11 
   41 Q 13268 Dehydrogenase/reductase SDR family member 2  11 
   58  P07339  Cathepsin D precursor   11 
   15  P31930 Ubiquinol-cytochrome-c reductase  12 
   46  P18669  Phosphoglycerate mutase   12 
   47  P60174 T riosephosphate isomerase   12 
   68 O75947  ATP synthase D chain  12 
   31  P06733  Alpha-enolase   12 
   88  P62937  Peptidyl-prolyl cis-trans isomerase A   12 
   89  P62937  Peptidyl-prolyl cis-trans isomerase A   12 
   12  P60709 Beta-actin  12 
a) 1, Small intestine; 2, Large intestine; 3, Caco-2 5d; 4, Caco-2 15d; 5, HT-29; 6, Hep G2; 7, TE 671. 
b) The abundances of blood-derived protein spots were subtracted from the total gel density for correct normalization. BMC Genomics 2007, 8:91 http://www.biomedcentral.com/1471-2164/8/91
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Protein profiles of differentiated Caco-2 cells and human small intestinal epithelial cells Figure 5
Protein profiles of differentiated Caco-2 cells and human small intestinal epithelial cells. 2-D pattern of 5-day-dif-
ferentiated Caco-2 cells (A) and small intestinal epithelial scrapings (B). Identified protein spots are indicated with spot num-
bers corresponding to those in Figure 3 and 4. When a spot number is indicated in bold/italic, this means that the spot could 
not be observed in the particular pattern.
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mixtures of nutrients, whereas in vitro cells are probably
adapted to the culture medium with a rather simple com-
position.
Prohibitin is present as two spots in the gels, from which
one spot (no. 61, cluster 1) shows a strong expression
whereas the other spot (no. 62, cluster 4) shows a low
expression in the epithelial scrapings, compared to the
cultured cells. Similarly, two spots were identified as
myosin light polypeptide 6 (no. 80, cluster 4 and no. 79,
cluster 5) from which one spot is absent in the epithelium
in vivo, while the other spot is as abundant as in most cell
lines. These data indicate that gene products might be
processed via alternative pathways in in vitro cell cultures.
Next to specific forms of prohibitin and myosin light
polypeptide 6, we identified more proteins with a typi-
cally higher expression in all cultured cells tested, and they
account also for the separation of in vitro and in vivo pro-
teomes. The higher expression levels of proteins discussed
below might be explained by the tumoural origin of the in
vitro cell lines tested here. Heterogeneous nuclear ribonu-
cleoproteins (HnRNPs) K, L and A2/B1 belong to a family
of proteins with central roles in DNA repair, telomere
elongation, cell signalling and in regulating gene expres-
sion at transcriptional and translational level. Through
these key cellular functions, individual hnRNPs have a
variety of potential roles in tumour development, and sev-
eral hnRNPs, under which hnRNP K and A2/B1 are up-
regulated in various cancers [23]. Translationally-control-
led tumour protein is also higher expressed in in vitro cul-
Protein profiles of human large intestinal epithelial cells, HT-29, Hep G2, and TE 671 cells Figure 6
Protein profiles of human large intestinal epithelial cells, HT-29, Hep G2, and TE 671 cells. 2-D pattern of large 
intestinal epithelial scrapings (A), HT-29 cells (B), Hep G2 cells (C) and TE 671 cells (D).
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tured cells. It is not a tumour-specific protein, although its
expression level tends to be higher in tumours, compared
to the corresponding normal tissue [24]. The protein is
highly conserved and widely expressed in all eukaryotic
organisms, and is thought to be important for cell growth
and division [25]. Several heat shock proteins (HSPs),
such as 78-kDa glucose-regulated protein, 10-kDa HSP
and 60-kDa HSP are also higher expressed in the cell lines.
It was demonstrated before that HSPs, under which 78-
kDa glucose-regulated protein, are expressed in increased
amounts in many tumours [26]. Recently, 10-kDa HSP
was shown to be increased in colorectal cancer tissue com-
pared to normal tissue [27]. Elevated HSP expression has
a cytoprotective role. For example, individual HSPs are
able to block the pathways of apoptosis, and hence appear
to play a role in tumour pathogenesis.
A set of proteins was higher expressed in all cells of epithe-
lial origin included in this analysis. Two enzymes with a
role in detoxification, monoamine-sulphating phenol sul-
fotransferase and thiosulfate sulfurtransferase, show such
an expression pattern. Expression of monoamine-sulphat-
ing phenol sulfotransferase was already demonstrated in
the human jejunal mucosa and the Caco-2 cell line
[28,29]. Thiosulfate sulfurtransferase activity was present
in the small intestine, colon and rectum of human [30],
but high activity of this enzyme was also shown in liver
and kidney of rat [31]. Annexin A4 shows a comparable
expression pattern. The protein belongs to a ubiquitous
family of Ca2+-dependent membrane-binding proteins
thought to be involved in membrane trafficking and
membrane organization within cells and is found at high
levels in many epithelial cells, where it is closely associ-
ated with the apical region [32]. Epithelial cell marker
protein 1, also called stratifin or 14-3-3 sigma, was also
highly expressed in the epithelial cells but was not
observed in the mesenchymal TE 671 cells. These data
indicate that Caco-2 cells as well as HT-29 cells express
proteins that are characteristic to human intestinal epithe-
lium in vivo, which is further supported by the findings
mentioned in next paragraph.
Proteins with a higher expression in the intestinal cell
lines Caco-2 and HT-29, and in both the small intestine
and colon epithelial scrapings, compared to negative con-
trols Hep G2 and TE 671, are hydroxymethylglutaryl-CoA
synthase, keratin type 1 cytoskeletal 20, and glutathione
S-transferase P. These proteins could have an important
role in gut epithelial cells, as all profiles of intestinal ori-
gin, being from in vitro cultures or scrapings, express them.
Keratin type 1 cytoskeletal 20 is such a protein identified
as a major cytoskeletal polypeptide of the human intesti-
nal epithelium [33], and is thought to have a role in the
intermediate filament organization in intestinal epithe-
lium [34]. Hydroxymethylglutaryl-CoA synthase is a con-
trol enzyme in the synthesis of ketone bodies, and is
highly expressed in liver and colon, and low in testis,
heart, skeletal muscle and kidney [35]. Expression in the
human small intestine is reported here for the first time.
Next, Caco-2 cells share common characteristics with
small epithelial scrapings. Proteins with a similar expres-
sion in both are succinate dehydrogenase, sulfotransferase
1A1, mitochondrial phosphoenolpyruvate carboxykinase,
ornithine aminotransferase, and heme-binding protein 1.
They can be used as markers for the small intestinal epi-
thelial phenotype of Caco-2 cells. Ornithine aminotrans-
ferase appears to be an important protein in the intestine,
and is down-regulated by glutamine depletion in Caco-2
cells and starvation in mouse small intestine [4,36]. This
key enzyme is present predominantly in the small intes-
tine and is involved in the conversion of glutamine to
ornithine. Ornithine is a precursor for polyamines,
known for their involvement in cell proliferation, cell dif-
ferentiation and repair for intestinal cells [37]. Mitochon-
drial phosphoenolpyruvate carboxykinase has an
important role in gluconeogenesis, where it catalyzes the
conversion of oxaloacetate to phosphoenolpyruvate. We
found that glutamine depletion in Caco-2 cells resulted in
a decreased expression of this protein [4]. From above
data, one can deduce that the Caco-2 cells express biolog-
ically important proteins at a similar level as in the small
intestine. Such typical similarities in expression are not
observed between Caco-2 cells and large intestinal scrap-
ings.
Proteins with a higher or lower expression in Caco-2 cells,
compared to all other protein isolates, were also observed,
and this information needs to be considered when study-
ing processes in which one of these proteins play an
important role. Mostly, protein expression of partially dif-
ferentiated Caco-2 cells equals that of fully differentiated
Caco-2 cells. Hep G2 cells have the highest plasma RBP
levels, which is in line with the liver being the major site
for plasma RBP synthesis, where it is secreted in the blood
for retinol transport to the peripheral tissues. However,
other sites of plasma RBP secretion are reported [38]. Epi-
thelial scrapings of the small and the large intestine con-
tain this protein as well; however, we cannot exclude the
possibility that it is derived from blood. The finding that
plasma RBP is expressed at comparable levels in Caco-2
cells supports the idea that intestinal cells can synthesize
the protein too. Recently, we have shown that plasma RBP
was down-regulated considerably by glutamine deficiency
in Caco-2 cells [4], and this may have relevance for the
intestinal condition in vivo. Proteins with a role in
cytoskeletal function and proteasome activity are present
throughout different clusters, which makes it difficult to
interpret data concerning these central cellular processes.
Some proteins involved in carbohydrate metabolism,BMC Genomics 2007, 8:91 http://www.biomedcentral.com/1471-2164/8/91
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namely triosephosphate isomerase, phosphoglycerate
mutase and alpha enolase are similarly expressed in all
samples (cell lines and scrapings) tested.
Conclusion
This study was designed to compare expression profiles of
widely used intestinal cell models with their in vivo coun-
terparts. PCA revealed that global protein expression of
intestinal epithelial scrapings differed considerably with
that of intestinal epithelial cell lines. In the cell lines,
explicit, highly expressed proteins probably correspond to
their tumoural origin, whereas several proteins with a low
or undetectable expression could be explained by their
adaptation to culture conditions. Numerous proteins
showed a similar expression in Caco-2 cells, HT-29 cells,
and both the intestinal scrapings, of which some appear
to be characteristic to human intestinal epithelium in vivo.
In addition, several biologically significant proteins are
expressed at comparable levels in Caco-2 cells and small
intestinal scrapings, indicating the usability of this in vitro
model. Caco-2 cells, however, appear to over-express as
well as under-express certain proteins, which needs to be
considered by scientists using this cell line. As a result,
care should be taken to prevent misinterpretation of in
vitro obtained findings when translating them to the in
vivo situation.
Methods
Materials
The Caco-2 and Hep G2 cell lines were obtained from the
American Type Culture Collection (Rockville, MD, USA).
The HT-29 and TE 671 cell lines were kindly provided by
Dr. J. Keijer (RIKILT, Wageningen, The Netherlands) and
Dr. M. De Baets (Dept. Neurology, Academical Hospital
Maastricht, Maastricht, The Netherlands), respectively.
Dulbecco's modified Eagle's medium (DMEM) and cell
culture supplements were purchased from Invitrogen
(Carlsbad, CA, USA) except fetal calf serum (FCS) which
was from Bodinco (Alkmaar, The Netherlands). CHAPS,
dithiothreitol (DTT), iodoacetamide, α-cyano-4-hydroxy-
cinnamic acid, alcohol dehydrogenase and adrenocortico-
tropic hormone fragment 18–39 were from Sigma (St.
Louis, MO, USA). Urea, SYPRO Ruby Protein Stain and all
reagents for SDS-PAGE were from Bio-Rad Laboratories
(Hercules, CA, USA). Immobiline Dry Strips (pH 3–11,
nonlinear) and immobilized pH gradient (IPG) buffer
(pH 3–10, nonlinear) were from Amersham Biosciences
(Little Chalfont, England). Sequencing grade modified
trypsin was obtained from Promega (Madison, WI, USA).
Cell culture
All cells were cultured in DMEM supplemented with 1%
v/v non-essential amino acid solution, 100 units/mL pen-
icillin and 100 μg/mL streptomycin. For the Caco-2 cell
line, 20% v/v FCS was added to this medium, whereas
10% v/v FCS was added for the other cell lines. Caco-2
cells were grown until confluence for 6 days onto 24 mm
Transwell bicameral systems (Corning, Aston, MA, USA)
with collagen-coated membranes (0.4 μm pore size, 4.7
cm2 surface area). After this period, cells were maintained
in culture to differentiate for 5 and 15 days, representing
a partially and a fully differentiated enterocytic pheno-
type, respectively. Human Hep G2 and HT-29 cells were
cultured until confluence. The human muscle cell line TE
671 underwent myogenic differentiation for five days
with 10-7 M 12-O-tetradecanoylphorbol-13-acetate (TPA)
[39,40]. We also tested TE 671 cells not differentiated with
TPA, but 2-D patterns were similar and for that reason left
out of all analyses.
Sample preparation
Cell lines: the cells were washed three times with PBS. Pro-
teins were isolated from the cell lines by scraping them in
ice-cold PBS, and centrifuging the obtained cell suspen-
sions at 350 g for 5 min at 4°C. Cell pellets were dissolved
in a cell lysis buffer containing 8 M urea, 2% (w/v)
CHAPS, 65 mM DTT, 0.5% (v/v) IPG buffer supple-
mented with Complete protease inhibitors (Roche
Applied Science, Indianapolis, IN, USA). This mixture was
subjected to three cycles of freeze thawing, vortexed thor-
oughly and centrifuged at 20000 g for 30 min at 10°C.
Supernatant was collected and stored at -80°C until fur-
ther analysis. For each cell line, protein isolates were
obtained from three independent cultures.
Epithelial scrapings: Epithelial scrapings of three small
intestinal samples and two colon (sigmoid colon) sam-
ples were obtained from patients who underwent Whip-
ple pancreatico-duodenectomy and colectomy as a
treatment for pancreas and colon cancer, respectively.
Such surgery implicates that large sections of the patients'
intestine need to be removed. The epithelium was scraped
from that intestinal tissue at least 10 cm removed from the
tumour. The samples were snap frozen in liquid nitrogen
and stored at -80°C until proteins were isolated. For pro-
tein isolation, samples were grinded in liquid nitrogen,
after which cell lysis buffer (see above) was added. The
rest was performed as described for the cell line material.
The samples were not pooled, as enough protein material
could be obtained by the scraping. An informed consent
was obtained from the patients.
The protein concentrations of all protein samples were
determined by a Bradford based protein assay [41].
2-DE
The 2-DE procedure was performed as described with
minor modifications [4]. Briefly, 200 μg of total protein
was separated by isoelectric focusing using Immobiline
Dry Strips (24 cm, pH 3–11, nonlinear) according to theBMC Genomics 2007, 8:91 http://www.biomedcentral.com/1471-2164/8/91
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following protocol: 12 h at 30 V, 1 h at 500 V, 1 h at 1000
V, 2 h gradient from 1000 to 8000 V, 35 kVh at 8000 V.
Strips were equilibrated and placed onto 12.5% SDS-poly-
acrylamide gels for protein separation in the second
dimension. Electrophoresis was conducted at 200 V con-
stantly for 6 h in a 24 cm Protein Dodeca Cell (Bio-Rad
Laboratories). The gels were stained with SYPRO Ruby
Protein Stain according to the manufacturer's protocol
and the proteins were visualized by scanning gels with the
Molecular Imager FX (Bio-Rad Laboratories).
Gel image and data analysis
Spot detection, matching and the examination of differen-
tially expressed proteins was performed using PDQuest
v7.3 (Bio-Rad Laboratories). Three biological replicates
were made per condition and formed one replicate group
with average normalized spot intensities. Initially, spot
abundances were normalized with respect to the total gel
density. However, to evaluate the effect of the contaminat-
ing, blood-derived proteins, the abundances (see Addi-
tional file 2) were normalized with respect to the total gel
density subtracted with the density of blood proteins. A
spot was regarded as significantly differentially expressed
between groups if the average spot intensity differed 1.4-
fold or more and if P < 0.05 (Student's t-test) for at least
one comparison. GeneMaths XT software (Sint-Martens-
Latem, Belgium) was used to produce a dendogram using
the unsupervised hierarchical clustering method
Unweighted Pair Group Method with Arithmetic Means
(UPGMA) based on the Pearson correlation coefficients.
In addition, PCA was applied on the protein data, and
both were used as exploratory data analysis tools to com-
pare protein spot patterns derived from the used tissues
and cell lines.
In-gel digestion
For identification, protein spots were excised from the gel
using an automated spot cutter (Bio-Rad Laboratories)
and processed on a MassPREP digestion robot (Waters,
Manchester, UK). A solution of 50 mM ammonium bicar-
bonate in 50% v/v acetonitrile was used for SYPRO Ruby
destaining. Cysteines were reduced with 10 mM DTT in
100 mM ammonium bicarbonate for 30 minutes fol-
lowed by alkylation with 55 mM iodoacetamide in 100
mM ammonium bicarbonate for 20 minutes. Spots were
washed with 100 mM ammonium bicarbonate to remove
excess reagents and were subsequently dehydrated with
100% acetonitrile. Trypsin (6 ng/μl) in 50 mM ammo-
nium bicarbonate was added to the gel plug and incuba-
tion was preformed at 37°C for 5 h. The peptides were
extracted with 1% (v/v) formic acid/2% (v/v) acetonitrile.
MALDI-TOF MS
For MALDI-TOF MS 1.5 μl of each peptide mixture and
0.5 μl matrix solution (2.5 mg/ml α-cyano-4-hydroxycin-
namic acid in 50% acetonitrile/0.1% TFA) was spotted
automatically onto a 96 well-format target plate. The
spots were allowed to air dry for homogeneous crystalliza-
tion. Spectra were obtained using an M@LDI-LR mass
spectrometer (Waters). The instrument was operated in
positive reflector mode. Acquisition mass range was 800–
4000 Da. The instrument was calibrated on 10–12 refer-
ence masses from a tryptic digest of alcohol dehydroge-
nase. In addition, a near point lockmass correction for
each sample spot was performed using adrenocortico-
tropic hormone fragment 18–39 (MH+2465.199) to
achieve maximum mass accuracy. Typically 120 shots
were combined and background subtracted. A peptide
mass list was generated for the subsequent database
search [42,43].
Database search
The peptide mass list generated with MassLynx v4.0.5 was
searched with ProteinLynx Global Server v2.0.5 (Waters)
or Mascot Search Engine [44] against the Swiss-Prot Data-
base [45] for protein identification. Taxonomy was set to
Homo sapiens and Mascot probability scores were calcu-
lated using 30 mass peaks or less with highest signal inten-
sity, trypsin and keratin peaks were excluded. One miss-
cleavage was tolerated; carbamidomethylation was set as
a fixed modification and oxidation of methionine as an
optional modification. The peptide mass tolerance was set
to 100 ppm. No restrictions were made on the protein
molecular weight and the isoelectric point. A protein was
regarded identified when it had a significant Mascot prob-
ability score (scores greater than 60 correspond to P <
0.05), and at least four matched peptides, from which dif-
ferent forms of the same peptide were excluded.
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